|
LATEST NEWS
Feb 1, 2008 -Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients more »
Nov 29, 2007 -Neuro-Hitech Announces Private Offering of $5.0 Million more »
Dec 14, 2007 -Neuro-Hitech Announces Completion of Double-Blind Part of Phase Two Clinical Trial of Huperzine A in Alzheimer's Disease more »
Nov 29, 2007 -Neuro-Hitech Announces Private Offering of $5.0 Million more »
August 28, 2007 -Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer more »
June 11, 2007 - Neuro-Hitech, Inc. (NHPI) Completes Patient Enrollment for U.S. Phase II Clinical Trial of Huperzine A more »
June 5, 2007 - Neuro-Hitech's Scientific Advisory Board Member Awarded $1 Million Grant to Advance Disease Modifying Alzheimer's Compounds more »
May 30, 2007 - Neuro-Hitech, Inc., Obtains Exclusive License to Combination Drugs for the Treatment of Alzheimer's Disease and Other Serious Neurological Disorders Read more »
|
